Clarithromycin-containing triple therapy for Helicobacter pylori eradication is inducing increased long-term resistant bacteria communities in the gut.

Authors :: Sjomina O
Vangravs R
Ļeonova E
Poļaka I
Pūpola D
Čivkulis K
Jeniceka A
Paršutins S
Stonāns I
Park JY
Engstrand L
Leja M
Source :: Gut [Gut] 2024 Jun 06; Vol. 73 (7), pp. 1214-1215. Date of Electronic Publication: 2024 Jun 06.
Publication Year :: 2024
Abstract: Competing Interests: Competing interests: None declared.

Subjects :: Humans
Drug Resistance, Bacterial
Proton Pump Inhibitors administration & dosage
Clarithromycin therapeutic use
Clarithromycin administration & dosage
Helicobacter pylori drug effects
Helicobacter Infections drug therapy
Anti-Bacterial Agents therapeutic use
Drug Therapy, Combination
Gastrointestinal Microbiome drug effects

Full Text Access

Tools